Predictors of Decline in Renal Function 5 Years after EVAR.


Journal

Vascular and endovascular surgery
ISSN: 1938-9116
Titre abrégé: Vasc Endovascular Surg
Pays: United States
ID NLM: 101136421

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 26 10 2021
medline: 27 1 2022
entrez: 25 10 2021
Statut: ppublish

Résumé

While there exists copious short-term data regarding renal function following infra-renal endovascular abdominal aortic aneurysm repair (EVAR), long-term analysis is sparse. This is a single institution retrospective review of predictors of renal function decline 5 years after elective EVAR. All EVAR between 2007 and 2015 were queried. Patients in whom renal function was documented 5 years postoperatively were included in analysis. Exclusion criteria were ruptured aneurysm, mortality before 56 months, lack of follow-up, ESRD status, and concomitant renal intervention. The primary outcome investigated was a 20% or greater drop in glomerular filtration rate (GFR) 5 years postoperatively. The following variables at the time of surgery were investigated as potential predictors: age, gender, hypertension, hyperlipidemia, diabetes, CAD or prior MI, COPD, prior stroke, baseline eGFR under 60 mL/min/1.73 m 354 EVAR were identified of which 143 met inclusion criteria (211 excluded). Univariate analysis revealed female gender (OR 2.7), hypertension (OR 9.4), baseline renal insufficiency (OR 3.8), larger neck diameter, and supra-renal fixation (OR 2.32) all predictive ( Females and patients with baseline renal insufficiency are more vulnerable to significant decline in renal function 5 years following EVAR. Consistent with analogous literature, supra-renal fixation appears moderately deleterious toward renal function with no clinical significance in those with baseline normal renal function. The potential benefit of avoidance of supra-renal fixation in female patients with baseline renal insufficiency is worth further investigation in a more robust multi-center study.

Identifiants

pubmed: 34694174
doi: 10.1177/15385744211054283
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-172

Auteurs

Matthew Blecha (M)

Division of Vascular Surgery and Endovascular Therapy, 23356Loyola University Health System, Maywood, IL, USA.

Lillian Malach (L)

12248Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.

Brooke Dickens (B)

12248Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.

Emily Decicco (E)

12248Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.

Melissa D'Andrea (M)

12248Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.

Matthew DeJong (M)

12248Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.

Carlos F Bechara (CF)

Division of Vascular Surgery and Endovascular Therapy, 23356Loyola University Health System, Maywood, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH